February 28, 2014
Calabasas, Calif., February 28, 2014 – KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Cowen and Company 34th Annual Health Care Conference in Boston, MA.
Event: Cowen and Company 34th Annual Health Care Conference
Date: Tuesday, March 4, 2014
Time: 8:40 a.m. ET
A live webcast will be available under the Investors section of the Company’s website at www.kytherabiopharma.com. The presentation will be archived on the website and will be available for at least 14 days.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s product candidate, ATX-101, is currently in late stage clinical trials for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.
Associate Director, Investor Relations